The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
VJVirtual | Lineage plasticity in lung cancer: biological & therapeutic implications
Triparna Sen, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, discusses lineage plasticity and its implication in the development of lung cancer, as well as resistance to therapeutics. The results of an in-depth characterization of neuroendocrine transformation in lung cancer is presented and highlight a new landscape of potential drivers and targetable mutations of neuroendocrine transformation in lung cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).
